People

Adam Knight

Adam Knight, PhD is a cofounder and partner of Neuro.VC, focusing on therapeutics for neurodegenerative diseases. Primary MJFF and UniversityofAlabama biographies describe his previous founder/CEO/CBO roles at Neuron23 and work translating genetically defined neuroscience into drug development. He studied biological sciences at Alabama and completed a doctorate at Cambridge; earlier professional experience includes KleinerPerkins, IQVIA and MiltenyiBiotec. Earlier Neuron23 fundraising is not a Neuro.VC fund close.